CHI3L1 and endothelial dysfunction: Growing clinical evidence has indicated that aberrant expression of YKL-40 is largely associated with endothelial dysfunction [14], [29]–[31] and poor cardiovascular outcome [19], [20], suggesting that serum levels of YKL-40 can serve as a diagnostic and prognostic biomarker.